- Home
- SMLR vs SPXX Comparison
SMLR vs SPXX Comparison
Compare SMLR & SPXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMLR
- SPXX
- Stock Information
- Founded
- SMLR 2007
- SPXX 2004
- Country
- SMLR United States
- SPXX United States
- Employees
- SMLR N/A
- SPXX N/A
- Industry
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SPXX Trusts Except Educational Religious and Charitable
- Sector
- SMLR Health Care
- SPXX Finance
- Exchange
- SMLR Nasdaq
- SPXX Nasdaq
- Market Cap
- SMLR 289.5M
- SPXX 302.8M
- IPO Year
- SMLR 2014
- SPXX N/A
- Fundamental
- Price
- SMLR $61.75
- SPXX $17.86
- Analyst Decision
- SMLR
- SPXX
- Analyst Count
- SMLR 0
- SPXX 0
- Target Price
- SMLR N/A
- SPXX N/A
- AVG Volume (30 Days)
- SMLR 1.1M
- SPXX 51.3K
- Earning Date
- SMLR 11-04-2024
- SPXX 01-01-0001
- Dividend Yield
- SMLR N/A
- SPXX 7.55%
- EPS Growth
- SMLR N/A
- SPXX N/A
- EPS
- SMLR 2.04
- SPXX N/A
- Revenue
- SMLR $58,938,000.00
- SPXX N/A
- Revenue This Year
- SMLR N/A
- SPXX N/A
- Revenue Next Year
- SMLR N/A
- SPXX N/A
- P/E Ratio
- SMLR $30.30
- SPXX N/A
- Revenue Growth
- SMLR N/A
- SPXX N/A
- 52 Week Low
- SMLR $20.88
- SPXX $13.57
- 52 Week High
- SMLR $79.45
- SPXX $16.05
- Technical
- Relative Strength Index (RSI)
- SMLR 61.11
- SPXX 76.06
- Support Level
- SMLR $57.33
- SPXX $17.66
- Resistance Level
- SMLR $69.67
- SPXX $17.78
- Average True Range (ATR)
- SMLR 9.09
- SPXX 0.17
- MACD
- SMLR -0.32
- SPXX 0.03
- Stochastic Oscillator
- SMLR 51.22
- SPXX 100.00
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
About SPXX Nuveen S&P 500 Dynamic Overwrite Fund
Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio (with a 55% long-term target) in an effort to enhance the Fund's risk-adjusted returns.